XML 40 R30.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Schedule of contract liabilities

 

 

September 30,

2022

 

 

December 31,

2021

 

Customer deposits for commercial products

 

$388

 

 

$293

 

Summary of changes in contract liabilities

Balance at December 31, 2020

 

$994

 

Additions

 

 

435

 

Customer deposits returned

 

 

(713 )

Transfers to revenue

 

 

(208 )

Contract liabilities held for sale

 

 

(215 )

Balance at December 31, 2021

 

 

293

 

Additions

 

 

26

 

Customer deposits returned

 

 

(45 )

Transfers to revenue

 

 

(84 )

Contract liabilities held for sale but not assumed

 

 

198

 

Balance at September 30, 2022

 

$388

 

Summary of fair value measurements of assets and liabilities

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Fair value of contingent stock consideration

 

$917

 

 

$-

 

 

$-

 

 

$917

 

Fair value of Series A Note

 

$3,136

 

 

$-

 

 

$-

 

 

$3,136

 

Fair value of Series B Note

 

$6,848

 

 

$-

 

 

$-

 

 

$6,848

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Fair value of contingent stock consideration

 

$1,430

 

 

$-

 

 

$-

 

 

$1,430

 

Fair value of Series A Note

 

$3,075

 

 

$-

 

 

$-

 

 

$3,075

 

Fair value of Series B Note

 

$6,857

 

 

$-

 

 

$-

 

 

$6,857

 

Schedule of asets and liabilities measured at fair value

Fair value at December 31, 2021

 

$9,932

 

Change in fair value of Series A Note

 

 

61

 

Change in fair value of Series B Note

 

 

657

 

Conversion of Series B Note

 

 

(666 )

Fair value of Series A and B Notes at September 30, 2022

 

$9,984

 

Schedule of financial instruments

Date of valuation

 

September 30,

2022

 

 

December 31, 

2021

 

Stock price

 

$0.26

 

 

$0.36

 

Conversion price

 

$1.32

 

 

$1.32

 

Term (in years) – Series A Note

 

 

0.08

 

 

 

0.83

 

Term (in years) – Series B Note

 

 

0.08

 

 

 

0.13

 

Volatility – Series A Note

 

 

70%

 

 

85%

Volatility – Series B Note

 

 

70%

 

 

65%

Risk-free interest rate – Series A Note

 

 

2.75%

 

 

0.32%

Risk-free interest rate – Series B Note

 

 

2.75%

 

 

0.06%

Interest rate

 

 

18%

 

 

18%
Schedule of basic and diluted loss per share

 

 

For the Three Months Ended

 

 

For the Nine Months Ended

 

(Dollars in thousands)

 

September 30,

2022

 

 

September 30,

2021

 

 

September 30,

2022

 

 

September 30,

2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from continuing operations

 

$(2,909)

 

$(3,307)

 

$(11,396)

 

$(6,152)

Loss from disposal group

 

 

(684)

 

 

(1,036)

 

 

(6,967)

 

 

(2,683)

Net loss

 

$(3,593)

 

$(4,343)

 

$(18,363)

 

$(8,835)

Weighted average outstanding shares of common stock

 

 

70,686,677

 

 

 

62,174,822

 

 

 

69,808,785

 

 

 

49,294,190

 

Common stock and common stock equivalents

 

 

70,686,677

 

 

 

62,174,822

 

 

 

69,808,785

 

 

 

49,294,190

 

Basic and diluted loss per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$(0.04)

 

$(0.05)

 

$(0.16)

 

$(0.12)

Disposal group

 

$(0.01)

 

$(0.02)

 

$(0.10)

 

$(0.05)
Schedule of asets and liabilities measured at fair value

 

 

Nine months ended September 30,

 

 

 

2022

 

 

2021

 

 

 

 

 

 

 

 

Vested stock options from the Company’s 2017 Equity Incentive Plan

 

 

3,173,469

 

 

 

3,845,124

 

Warrants

 

 

615,530

 

 

 

1,565,447

 

Shares to be issued upon conversion of convertible payable

 

 

115,047

 

 

 

115,047

 

 

 

 

 

 

 

 

 

 

Total

 

 

3,904,046

 

 

 

5,525,618